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Abstract
Background: The outermost layer of mycobacterial cell wall is rich in lipids and glycolipids, surface molecules
which differ among species. Mycobacterium smegmatis, an attractive model for the study of both pathogenic and
non-pathogenic mycobacteria, presents glycopeptidolipids (GPLs). All the genes necessary for the biosynthesis of
such molecules are clustered in a single region of 65 kb and among them, the msmeg_0412 gene has not been
characterized yet. Here we report the isolation and subsequent analysis of a MSMEG_0412 null mutant strain.
Results: The inactivation of the msmeg_0412 gene had a drastic impact on bacterial surface properties which
resulted in the lack of sliding motility, altered biofilm formation and enhanced drug susceptibility. The GPLs analysis
showed that the observed mutant phenotype was due to GPLs deficiencies on the mycobacterial cell wall. In
addition, we report that the expression of the gene is enhanced in the presence of lipidic substrates and that the
encoded protein has a membrane localization.
Conclusion: msmeg_0412 plays a crucial role for GPLs production and translocation on M. smegmatis surface. Its
deletion alters the surface properties and the antibiotic permeability of the mycobacterial cell barrier.
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Background
Mycobacterial cell wall is a unique well organized barrier
which confers low permeability to different chemical
agents and common antibiotics [1]. The envelope is
waxy, hydrophobic, and thicker compared to that of
other bacteria and is organized in two compartments,
the inner layer, covalently linked to the plasma mem-
brane and formed by peptidoglycan, arabinogalactan and
mycolic acid, and, the outer layer, which is essentially
formed by glycolipids and proteins [2, 3]. Glycopeptido-
lipids (GPLs) are the major surface exposed molecules
found in various mycobacterial species including non-
pathogenic (e.gM. smegmatis) and non–tuberculous
pathogenic mycobacteria (e.g. M. avium, M. intracellu-
lare, M. abscessus) [4, 5]. GPLs have a common fatty
acyl-tetrapeptide core which is glycosylated with
6-deoxy-L-talose and variable O-methyl-L-rhamnose resi-
dues [6–8]. This is known as non-serovar-specific GPL
(nsGPLs) and represents the main product of M.
smegmatis GPLs. In M. avium GPLs present a more
complicated structure in which an additional rhamnose
and oligosaccharide residues are added to 6-deoxy-L-
talose, resulting in serovar-specific GPLs [7, 9, 10].
These molecules, which may represent more than 70 %
of total surface lipids [11], are required for cell aggrega-
tion, sliding motility and biofilm formation [12–15].
Moreover several studies reported that slight modifica-
tions of the GPLs structure are able to affect the
mycobacterial ability to stimulate the host immune re-
sponse, suggesting a role as antigenic molecules [16–19].
The fast growing M. smegmatis is frequently used as a
model organism to study the molecular and physio-
logical mechanisms used by slow-growing pathogenic
mycobacteria. The M. smegmatis GPLs biosynthetic
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locus has been previously characterized either experi-
mentally or by in silico prediction [20–23]. Most genes
of the M. smegmatis GPL locus are conserved in two
clinically significant mycobacterial species such as M.
abscessus and M. avium subsp. paratuberculosis [5, 24].
Among them, the gene msmeg_0412 is still uncharac-
terized and its product shares 66 % and 67 % identity
with the predicted protein MAB_0402, and MAP2244
from M. abscessus and M. avium subsp. paratuberculo-
sis, respectively. Interestingly, M. tuberculosis, a myco-
bacterium which does not produce GPLs on the cell
wall, presents Rv1184c which shares 45 % identity with
MSMEG_0412. Rv1184c has been recently characterized
as the Acyltransferase Chp2, essential for the final bio-
synthetic steps of polyacyltrehalose (PAT), a pentaacy-
lated, trehalose-based glycolipids only found on the
surface of pathogenic mycobacteria [25, 26].
In this study we show that the inactivation of
msmeg_0412 gene alters the lipid profile surface of M.
smegmatis and enhances the bacterial susceptibility to
antibiotics. In addition, we report that msmeg_0412 gene
expression is enhanced in the presence of lipidic sub-
strates and that the encoded protein localizes on the cell
wall. Taken together, our results indicate that
MSMEG_0412 is an important player in the complex
GPLs biosynthetic process in M. smegmatis and allow
speculating that MSMEG_0412 is translocated to the cell
wall where it contributes to GPLs synthesis.
Results
Deletion of the msmeg_0412 gene alters M. smegmatis
surface properties, enhances suscepitibility to antibiotics
and affects GPLs synthesis
The msmeg_0412 gene (Fig. 1a) belongs to a gene cluster
devoted to the biosynthesis and transport of GPLs to
mycobacterial cell wall surface. Most of the genes inside
the cluster have been previously characterized [5, 15]. In
particular, mps1 and mps2 genes encode the mycobacter-
ial peptide synthetase required for the formation of
tripeptide-amino-alcohol moiety which is then linked to
the 3-hydroxy/methoxy C26-C34 acyl chain, the lipid
moiety of GPLs. The latter is synthesized by the com-
bined action of Pks, Fad23 and PapA3 gene products. Fi-
nally, the action of various glycosyltransferases (Gtf ),
methyltransferases (Mtf ) and acetyltransferases (Atf )
leads to the building of the glycosyl side of GPLs. Once
synthesized, GPLs are transferred to GPL addressing
protein (Gap), a small integral membrane protein, re-
quired for the translocation of GPLs on the cell surface.
As shown in Fig. 1a, the msmeg_0412 gene is close to
Fig. 1 a) Schematic representation of the GPLs structure from M. smegmatis and its biosynthetic locus on the chromosome. The genes involved
in the synthesis of lipid moiety (orange), peptide (green) and glycosylation (red) of GPLs are indicated. b) Agarose gel electrophoresis showing
PCR-based validation of the msmeg_0412 gene deletion in the GM1 strain. Lanes: 1) DNA Ladder marker (1Kb); 2) PCR negative control; 3) wt
Chromosomal DNA used as template (2527 bp-amplicon expected using 0412-F1 and 0412-R2 as primers); 4) GM1 Chromosomal DNA used as
template (1438 bp-amplicon expected using 0412-F1 and 0412-R2 as primers)
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the genes involved in the synthesis of lipid portion of
GPLs. In order to understand the role of the
msmeg_0412 gene product, we constructed a null mu-
tant strain by using the pGOAL/pNIL procedure as re-
ported in methods. A PCR confirmation of gene deletion
in GM1 strain is shown in Fig. 1b. The deletion mutant,
GM1, was analyzed for some phenotypes . Compared to
its isogenic wild type strain, GM1 displayed altered bio-
film formation (Fig. 2a), lack of sliding motility (Fig. 2b),
and rough colony phenotype (Fig. 2c).
To confirm that these phenotypes were due to
msmeg_0412 gene inactivation, we performed a comple-
mentation analysis. A wild type allele of the msmeg_0412
gene was PCR-amplified, cloned into pMV10-25 vector
[27] without the gfp gene (methods), and transformed
into strain GM1, yielding strain GM2. As shown in Fig. 2
all phenotypes of strain GM1 were rescued in strain
GM2, that appeared identical to the wild type strain.
The drastic impact of msmeg_0412 deletion on M.
smegmatis surface properties was also evidenced by a
slower growth rate in liquid media with a generation
time of the mutant of 4.5 h compared to 3 h of the wt
strain (see Additional file 1: Figure S1) and by the en-
hanced susceptibility to antimicrobials. As shown in
Fig. 2d, when streaked on LB agar medium containing
Rifampicin at a sub-MIC concentration (10 μg/ml) [28],
the GM1 strain was unable to grow compared to the
wild type and complemented strains. The same result
was obtained using Erythromycin as antibiotic (13 μg/
ml) [29]. Since both antibiotics have cytosolic targets, it
is possible to hypothesize that the mutation induces
changes in the cell wall permeability that lead to an in-
crease in antibiotics penetration.
To better characterize the effects of msmeg_0412 dele-
tion we extracted and analyzed the GPLs content from
the wild type, mutant and complemented strains. TLC
analysis of the three organic extracts (Fig. 3a) indicated
that GPLs were absent only in GM1 while they were
equally abundant in the remaining strains. Conversely,
the occurrence of the lipid fraction was detected in both
wt, GM1 and GM2 strains (see Additional file 2: Figure
S2). An even more accurate picture was provided by
ESI-MS analysis (Fig. 3b). In this case, wt and GM2
strains provided identical MS profiles, which could be
referred to the occurrence of 6-deoxy-L-talose- and O-
methyl-L-rhamnose-containing GPLs and their methyl-
ated congeners [23]. Conversely, no traces of any
sugar-containing compound at the same m/z range was
found in GM1. The lack of GPLs in the msmeg_0412 de-
letion mutant apparently suggests that msmeg_0412 gene
product is involved in the synthesis and assembly of
GPLs on the M. smegmatis cell wall.
The msmeg_0412 gene expression is induced by lipid
substrates
In order to evaluate the role played by MSMEG_0412
protein during GPLs production a bioinformatics
approach was initially followed. MSMEG_0412 has the
canonical penta-peptide sequence motif GXSXG/S and
the conserved Ser, Asp and His catalytic triad (indicated
in bold in Fig. 4) typical of proteins with lipase/esterase
activity and identified as hydrolases involved in lipid
metabolism [30, 31].
To experimentally validate the bioinformatic prediction
we monitored the effects of two widely used lipid sub-
strates, tributyrin and tween 80, on the transcriptional
Fig. 2 Phenotypic analysis of M. smegmatis strains. Wild-type strain was compared to msmeg_0412 null mutant (GM1) and complemented (GM2)
strains for the following phenotypes: Biofilm production (a), Sliding motility (b) Colony morphology (c). The same strains were streaked on LB agar
plates supplemented with or without Rifampicin (10 μg/ml) to evaluate the Antimicrobial susceptibility towards this antibiotic (d)
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profile of the msmeg_0412 gene. To this purpose M. smeg-
matis wild type strain was grown in minimal medium
containing glucose, tributyrin or tween 80 as the only
carbon source and total RNA was extracted and reverse
transcribed as reported in methods. As shown in Fig. 5,
the transcriptional level of the gene was induced approxi-
mately 50-fold in the presence of tween 80 and 2-fold in
the presence of tributyrin.
Based on this result we decided to evaluate the effect of
tween 80 on the growth of the mutant strain. To this pur-
pose wt, GM1 and GM2 strains were grown in minimal
medium containing 0.2 % (w/v) glucose or 1%t ween 80 as
the only carbon source. The result (see Additional file 3:
Figure S3) clearly indicated that the mutant was unable to
grow in presence of tween 80. Although this result,
together with the bioinformatic analysis, allows speculat-
ing a lipolytic function for MSMEG_0412, a detailed
biochemical characterization is needed to decipher its
function.
The MSMEG_0412 protein is localized on the cell wall
In silico analysis suggested that MSMEG_0412 contains
a N-terminal signal sequence (underlined in Fig. 4) with
a putative cleavage site between residues A29 and D30,
most likely involved in targeting the MSMEG_0412 to
the cell membrane. To validate this prediction we
constructed two gene fusions between gfp, the gene
encoding for the Green Fluorescent Protein, and the
msmeg_0412 gene with and without the sequence coding
for the putative signal peptide (Methods). The gene
Fig. 3 Chemical analysis of GPLs. GPLs content from the wild-type, GM1 and GM2 strains as indicated by TLC analysis (a) and ESI-MS profile of
the organic extracts (b)
Fig. 4 Amino acid sequence of MSMEG_0412. In bold is reported the conserved pentapeptide sequence motif GXSXG/S. Aminoacid residues
potentially involved in the catalytic triad are indicated by an asterisk (*). Underlined is the putative N-terminal signal peptide
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fusions were independently used to transform M. smeg-
matis wild type cells, yielding strains GM7 (carrying the
entire msmeg_0412 gene) and GM8 (carrying the
msmeg_0412 gene without the signal peptide). A fluores-
cence microscopy analysis showed that the fluorescence
signal was localized around the cells of strain GM7 and
inside the cells of strain GM8 (Fig. 6). This result indi-
cates that MSMEG_0412 is a membrane protein and
that the removal of the signal peptide induces protein
aggregation and its retention within the cytosol.
Fig. 5 Real-Time PCR analysis of msmeg_0412 gene under different growth conditions. Cells of M. smegmatis mc2155 wild type strain were grown
in aerated conditions in minimal medium containing glucose, tributyrin or tween 80 to early exponential growth phase. The ΔΔCt method was
used to calculate the relative amount of specific RNA present in each sample, and the transcriptional induction determined by comparison to
values from cells growing in minimal medium containing glucose
Fig. 6 Fluorescence analysis. M. smegmatis strains carrying gene fusions between gfp and msmeg_0412 gene with (GM7) and without (GM8) the
region coding for the putative signal peptide were analysed by phase contrast (PC) and Fluorescent (F) microscopy. Exposure time was 200 ms in
both cases
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Discussion
Mycobacteria comprise bacilli with a specialized cell wall
divided in two compartments: the inner- and the outer-
layer. The latter is rich in lipids and glycolipids which
differ among species. M. smegmatis shares a richness in
glycopeptidolipids (GPLs) with pathogenic non tubercle
mycobacteria, such as M. abscessus and M. avium.
Msmeg_0412, a gene located in the GPLs biosynthetic
locus, is highly conserved among mycobacteria, and its
product shares 45 % identity with Rv1184c from the
human pathogen M. tuberculosis. The gene encodes a
protein which primary structure has features of proteins
annotated as putative lipases or esterases.
Lipase/esterase-like enzymes belong to a family of
proteins involved in lipid metabolism, which play a
crucial role during mycobacterial infection and persist-
ence inside the host [30, 32]. In fact, it has been reported
that such enzymes contribute to the destruction of the
host tissues thereby supplying nutrients to the pathogens
[33, 34]. Therefore, a better understanding of these pro-
teins will surely help in developing new strategies against
mycobacterial infections.
Earlier reports have clearly indicated that the loss of
GPLs on M. smegmatis surface induce an increased cell
wall hydrophobicity [14, 15, 23] which results in the al-
teration of surface properties such as a change of colony
morphotype (from smooth to rough), an altered biofilm
formation at liquid/air interface, and the inability to slide
on soft agar plates. Here we report the construction and
analysis of a M. smegmatis strain carrying a null muta-
tion in msmeg_0412 gene.
Our results show that MSMEG_0412 is required for
the correct processing of the GPLs on mycobacterial
surface and that its deletion induced a surface perturb-
ation. Furthermore, in line with the bioinformatic pre-
dictions, the msmeg_0412 gene expression is enhanced
in the presence of lipid substrates, and the protein
encoded localizes on the cell wall. Taken together our
results allow to speculate that once synthesized,
MSMEG_0412 is translocated to the cell wall, where
plays a crucial role for the correct GPLs processing and
translocation on M. smegmatis surface. A further bio-
chemical approach is needed to better clarify other as-
pects of the function and the localization of this
important protein.
Conclusions
The analysis of msmeg_0412 mutant highlighted that this
gene is important for Mycobacterium smegmatis surface
organization and resulted in different important pheno-
types, as lack of sliding motility, altered biofilm forma-
tion and enhanced drug susceptibility. The analysis of
Glycopeptidolipids (GPLs) component of bacterial sur-
face showed that the msmeg_0412 mutant was strongly
impaired for GPLs presence in the mycobacterial cell
wall. In addition, based on in-silico predictions, we
report that the expression of the gene is enhanced by
the presence of lipidic substrates and that the encoded
protein has a membrane localization.
Finally, generation time of the mutant was shorter
than the one of the wild type strain.
Mutations affecting the organization of the cell wall
have often pleiotropic effects. This is the first experi-
mental evidence for an involvement of msmeg_0412
gene in the synthesis of the GPLs.
Taken together, the results presented in this manu-
script offer the possibility to consider MSMEG_0412 as
a new target to impair the mycobacterial growth and to
increase drug susceptibility.
Methods
Bacterial strains, media and growth conditions
M. smegmatis mc2155 [35] was the parental strain of all
the recombinant strains described below. DH5α (supE44
ΔlacU169 [ϕ80ΔlacZM15] hsdR17 recA1) [36] was used
for all cloning experiments.
The recombinant strain GM1, carrying a msmeg_0412
gene deletion was engineered using the p2NIL/pGOAL19-
based flexible cassette method as previously reported [37].
M. smegmatismc2155 and derivatives were grown in 7H9
medium (Difco) containing 2 % glycerol and 0.05 % tween
80 (Applichem) or in M9 containing 1 mM Mg2SO4 and
0.2 % glucose. Where indicated, glucose was replaced by
1 % glycerol-tributyrate (tributyrin) or 1 % tween 80.
E. coli strains were grown in LB medium. When re-
quired, antibiotics were added to the medium at the
following final concentrations: ampicillin 100 μg/ml,
hygromycin at 200 μg/ml for E. coli and 50 μg/ml for M.
smegmatis mc2155, respectively.
For the antimicrobial susceptibility test, Erythromycin
and Rifampicin were added to LB agar medium at the
following final concentrations: 13 μg/ml and 10 μg/ml
respectively.
For the Microscopy analysis, samples were observed
using an Olympus BX51 fluorescence microscope using
a FITC filter. The Images were captured using an
Olympus DP70 digital camera and processed. Standard
acquisition times were 200 ms.
Bioinformatic approach
A multiple sequence alignment was carried out using
PRALINE (http://www.ibi.vu.nl/programs/pralinewww)
as program. MSMEG_0412 aminoacid sequence was
used as query against the earlier identified M. tubercu-
losis proteins [31] showing the conserved pentapetide
sequence motif (GXGXG) and the conserved Ser, Asp
and His catalytic triad characteristic of lipase/esterase
activities.
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The signal peptide server, (http://www.cbs.dtu.dk/ser-
vices/SignalP), was used to predict the presence and
location of the signal peptide cleavage site inside
MSMEG_0412.
Sliding motility assay
5 μl of a liquid culture in stationary phase was dispensed
on plate containing 7H9 medium plus 0.3 % agar with
no added carbon source. The plate was then incubated
at 37 °C for 1 week [15, 23].
Congo red assays
5 μl of a liquid culture in stationary phase was dispensed
on plate containing LB medium supplemented with 2 %
agar and 100 μg/ml Congo Red (Sigma) and incubated
at 37 °C for 3 days [15, 23].
Biofilm assay
5 μl of a liquid culture in stationary phase was inocu-
lated into PVC well plates containing 5 ml Sauton liquid
medium and incubated in standing condition at 37 °C
for 1 week [15, 23].
DNA manipulation
Plasmid and chromosomal DNA preparation, restriction
digestion, ligation, bacterial transformation and agarose
gel electrophoresis were performed as described [36].
Plasmid pGM5 carries a gene deletion cassette (Δ0412
cassette) containing 689-bp segment upstream of
msmeg_0412 gene + first 4 codon (5’ fragment) followed
by last 15 codons + 685-bp segment downstream of the
gene (3’ fragment). The 5’ fragment was PCR amplified
using the primer pairs 0412-1 F and 0412-1R listed in
Table 1 and the genomic DNA of wild type mc2155
strain as template and the obtained PCR product was
cloned in pGEMT-easy vector, giving the plasmid
pGM2. The 3’ fragment was PCR amplified using the
primer pairs 0412-2 F and 0412-2R listed in Table 1 and
the genomic DNA of wild type mc2155 strain as tem-
plate and the obtained PCR product was digested with
KpnI and cloned in pGM2 vector at the unique KpnI
restriction site, giving plasmid pGM3. The deletion cas-
sette was then excised from pGM3 vector using the
restriction enzymes BamHI and SalI and transferred into
the p2NIL plasmid previously digested by the same re-
striction enzymes. The resulting plasmid, named pGM4
and the plasmid pGOAL19 were digested with PacI, and
the PacI selectable marker cassette of pGOAL19, carry-
ing the sacB, LacZ and Hyg genes, was ligated to the
linearized pGM4 to create the suicide vector pGM5.
Plasmid pGM6, used for complementation analysis,
was constructed as follow: the wild type msmeg_0412
gene from M. smegmatis wild type strain was PCR amp-
lified with Pfu Turbo high Fidelity DNA polymerase
(Stratagene) using chromosomal DNA as template and
the oligo 0412-Fw and 0412-Rv (Table 1) as primers.
The last ones contained the engineered NheI and BamHI
restriction sites respectively.
The PCR product of expected size was purified with a
PCR Purification Kit (Qiagen), digested with NheI and
BamHI restriction enzymes and cloned under the hsp60
promoter into the shuttle vector pMV10-25 [27], previ-
ously digested with the same enzyme pairs which
allowed the excision of the gfp encoding gene. The
resulting plasmid was controlled by sequencing and then
used to transform GM1 cells, giving the strain GM2.
Plasmid pGM7 and pGM8 containing the entire ver-
sion or the truncated version of the msmeg_0412 gene
fused to the gfp reporter gene, respectively, were con-
structed as follow: the msmeg_0412 gene except the stop
codon was PCR amplified with Pfu Turbo high Fidelity
DNA polymerase (Stratagene) using chromosomal DNA
as template and priming the reaction with two different
couples of primers: 0412-Fw and 0412-gfpRv or 0412-
Table 1 Synthetic oligonucleotides











aUnderlined is an unpaired tail carrying a restriction site
bPosition of annealing refers to msmeg_0412 gene sequence, with the first base of the translational initiation codon as +1
Zanfardino et al. BMC Microbiology  (2016) 16:267 Page 7 of 10
spFw and 0412-gfpRv (Table 1). The first couple of
primers has allowed to amplify the entire copy of the gene,
the other combination of primers has allowed to amplify
the gene that misses of 84 bp, encoding a putative
N-terminal signal peptide. All primers contained a 5’ engi-
neered NheI restriction site. The PCR products of
expected sizes were purified with the PCR purification Kit
(Qiagen) digested with the NheI restriction enzyme and
cloned in the plasmid pMV10-25 [27], under the control
of hsp60 promoter and in frame with GFP coding gene
using the NheI restriction site located at 5’ end of gfp.
The resulting plasmids were controlled by sequencing
and then used to transform M. smegmatis wild type cell,
giving the strains GM7 and GM8 respectively.
Isolation of Δmsmeg_0412 mutant strain
The msmeg_0412 null mutant strain, named GM1, was
obtained by using the allelic replacement system
reported previously [37].
The pGM5 suicide vector was used to transform cells
of M. smegmatis mc2155 strain and transformants were
selected on LB agar plates supplemented with hygromi-
cin (200 mg/ml), kanamycin (25 mg/ml) and X-Gal
(50 mg/ml). Blue colonies were restreaked onto LB agar
plates; a loopful of cells was then resuspended in LB
broth, serially diluted and plated on LB agar containing
2 % sucrose (Suc) and X-gal. White KanS, HygS and SucR
colonies were isolated and identified by PCR analysis.
One KanS, HygS and SucR colony with a deleted
msmeg_0412 gene was identified as GM1 strain.
RNA extraction
Total RNA was extracted by using the RNeasy Mini Kit
(QIAGEN) according to manufacturer’s protocol. RNAs
were resuspended in 100 ml of RNAse-free water and
treated with DNAse I (Fermentas, 1U/ml) for 30 minutes
at 37 °C. The quality of RNA samples were estimated
using the RNA nanochip on the Thermoscientific Nano-
drop 1000. The concentration of RNA was determined
by measuring the absorbance at 260 nm.
Real Time PCR analysis
cDNA was synthesized by using PrimeScript Enzyme
mix (Takara) and random hexamers as primers. Primers
0412-S and 0412-A (Table 1), and those for the normal-
izing gene 16S, 16S-fw (5′-GGCGAACGGGTGAGT
AACA-3′) and 16S-Rv (5′-GCCCTGCACTTTGGG
ATAAG-3′), were designed with ABI PRISM Primer Ex-
press software (PE Applied Biosystems). Real-Time PCR
was performed by using SYBR green RT-PCR (Takara).
Reactions were performed as previously described [38].
Values reported here were the average of at least three
independent experiments and were expressed as the
mean ± SEM (Standard Error of the Mean). The
fluorescence signal due to SYBR Green intercalation was
monitored to quantify the double-stranded DNA prod-
uct formed in each PCR cycle. Statistical significance
was determined by Student’s unpaired t-test and the sig-
nificance levels were reported in the text.
Extraction and analysis of mycobacterial lipids
Total lipids were extracted from whole cells as previ-
ously reported [16]. In brief, cells from wt, mutant and
complemented strains were grown in LB medium until
stationary phase (OD600: 2.5), harvested 10 minutes at
7000 rpm and resuspended in PBS, pH 7.4. Lipids were
extracted with CHCl3:CH3OH (1:2 v/v) for 24 hours,
separately dried under vacuum and partitioned between
water and chloroform (1:1 v/v).
The organic phases were further washed with distilled
water and evaporated to dryness. For analytical thin-
layer chromatography (TLC), the crude residues
(1.0 mg) were dissolved in CHCl3:CH3OH (0.75 mL,
9:1 v/v), spotted on silica gel 60-precoated plates (0.25-
mm thickness, Merck) and eluted with CHCl3:CH3OH
(9:1 v/v). Sugar-containing compounds were visualized
by spraying TLC plates with a chromosulfuric acid stain-
ing solution and charring them at 200 °C for 2 min. The
GPLs were detected as brownish-red spots. Conversely,
the lipid content in the three strains was detected by
extracting the crudes with hexane (0.3 mL). The result-
ing solutions were spotted on TLC plates which were
eluted in toluene:acetone (99:1 v/v). In this case, lipids
were visualized by spraying the plates with a cerium mo-
lybdate staining solution and charring them at 200 °C
for 2 min. The lipids were detected as dark blue spots.
ESI-MS analysis of the organic extracts was performed
using a Shimadzu LC-MS-2010EV system with ESI inter-
face, Q-array-octapole-quadrupole mass analyser and a
Shimadzu LC-MS solution Workstation software for
data processing. The optimized MS parameters were se-
lected as follows: CDL (curved desolvation line)
temperature 250 °C; heat block temperature 250 °C;
probe temperature 250 °C; detector gain 1.6 kV; probe
voltage +4.5 kV; CDL voltage -15 V. Nitrogen served as
nebulizing (flow rate: 1.5 L/min) and drying gas (flow
rate: 15 L/min). Each sample (0.5 mg) was dissolved in
1 mL of acetonitrile (ACN)/0.1 % trifluoroacetic acid
(TFA); 2 μL aliquots of the resulting solutions were
injected using ACN/0.1 % TFA as solvent (flow rate:
0.2 mL/min). MS spectra were acquired in positive ion
mode.
Additional files
Additional file 1: Figure S1. Growth curve of M. smegmatis strains in
LB medium. M. smegmatis wild type and GM1 strains were grown in LB
medium containg 0,05 % tween 80 and OD600nm determined every
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3 hours. For each strains the data reported in graph are the mean of
three independent experiments. (JPG 601 kb)
Additional file 2: Figure S2. Chemical analysis of total lipids. Total
lipids were extracted from whole wt, GM1 and GM2 cells and analyzed
by TLC. (JPG 483 kb)
Additional file 3: Figure S3. Growth curve of M. smegmatis strains in
Minimal medium. M. smegmatis wild type, GM1, GM2 strains were grown
in minimal medium containing 0.2 % (w/v) glucose or 1%t ween 80 as
the only carbon source. and OD600nm determined every 3 hours. For each
strains the data reported in graph are the mean of three independent
experiments. (JPG 710 kb)
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